Back to Search
IVANA MICALLEF, M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1346226370IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
42437(MN)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
42437(MN)
CMS Specialties
PrimaryHEMATOLOGY
Education
OTHER
Class of 1990
Research & Publications (20)
The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma.
PMID 17064990·Leuk Lymphoma·2006
8-other
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
PMID 17099879·Cancer·2006
3-trial
Ongoing trials with yttrium 90-labeled ibritumomab tiuxetan in patients with non-Hodgkin's lymphoma.
PMID 15498147·Clin Lymphoma·2004
6-review
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
PMID 19648970·Bone Marrow Transplant·2010
3-trial
Resolution of CD8+ lymphomatoid papulosis after surgical excision of the type AB-thymoma.
PMID 19542925·Am J Dermatopathol·2009
5-case
Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma.
PMID 19255322·J Clin Oncol·2009
3-trial
Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation.
PMID 19565646·Am J Hematol·2009
8-other
Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient.
PMID 19167685·Biol Blood Marrow Transplant·2009
3-trial
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.
PMID 19363221·Blood·2009
3-trial
Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study.
PMID 18541201·Biol Blood Marrow Transplant·2008
8-other
Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group.
PMID 18569634·Leuk Lymphoma·2008
3-trial
Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
PMID 18699848·Br J Haematol·2008
8-other
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative.
PMID 18828972·Mayo Clin Proc·2008
4-observational
Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
PMID 18492096·Br J Haematol·2008
4-observational
Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma.
PMID 18391991·Bone Marrow Transplant·2008
6-review
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.
PMID 18221391·Eur J Haematol·2008
8-other
Long-term outcome of allogeneic stem cell transplantation in chronic lymphocytic leukemia: analysis after a minimum follow-up of 5 years.
PMID 18798106·Leuk Lymphoma·2008
8-other
Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation.
PMID 18195687·Bone Marrow Transplant·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1346226370
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile